Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that it will release financial and operational results for the third quarter of 2023, on Thursday, November 2, 2023, before… Read More
WELL announces the launch of WELL AI Decision Support, to assist healthcare providers in improving early disease diagnosis and preventative health. WELL is exclusively partnering with HEALWELL AI, a leader… Read More
Expands EUDRACAP® brand with globally available size 9h enteric-coated capsule Seamless transition from preclinical to first-in-human trials with EUDRACAP® platform technology Reduces risk and variables for drug developers Evonik is launching… Read More
At the CHILD-BRIGHT Network, youth with brain-based disabilities between the ages of 16-29 form a National Youth Advisory Panel. They inform the work of the network and provide consultation services… Read More
Approximately 330 children with cystic fibrosis ages 2-5 years are now eligible for a medicine that treats the underlying cause of their disease TORONTO, ON — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)… Read More
